VASC Financial Facts

Cost of goods sold: 10.29M
Litigation: 0
See Full Income Statement

Total liabilities and shareholders' equity: 123.12M
Intangible assets, net: 10.61M
See Full Balance Sheet

Vascular Solutions (VASC) Earnings

  |   Expand Research on VASC
Next EPS Date 2/4/15 *Est. EPS Growth Rate -21.1% *Last Qtr.
Average EPS % Beat Rate +43.3% Revenue Growth Rate +13.9% *Last Qtr.
Average % Move 1-Wk after EPS +4.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/21/14 Q314 $0.15$0.20 -$0.05$31.9M$31.1M = Details
7/22/14 Q214 $0.20$0.18 +$0.02$30.7M$30.43M Details
4/22/14 Q114 $0.16N/A N/A $29.9M$26.1M Details
2/4/14 Q413 $0.22$0.19 +$0.03$29.1M$28.61M Details
10/22/13 Q313 $0.19$0.07 +$0.12$28M$27.1M Details
7/23/13 Q213 $0.17$0.17 $0.00$27.4M$27M Details
4/23/13 Q113 $0.16$0.15 +$0.01$26.1M$26.51M Details
2/5/13 Q412 $0.18$0.17 +$0.01$25.3M$25.59M Details